FDA NDC Directory · JSON-LD · Markdown

Vyvanse

NDC 59417-103 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namelisdexamfetamine dimesylate
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021977
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (30 mg/1)
Marketing started20070223
Package count1

External sources

Source: openFDA. Public-domain (CC0).